Sun Pharmaceutical Industries Analyzed: A Quick Look
Sun Pharmaceutical Industries’ stock price is currently at Rs 1712.2, showing a slight decrease of 0.29% today. This happens when the stock market is open. It’s important to understand that this price movement doesn’t happen in a vacuum – it’s part of a bigger picture of how the company is performing compared to other businesses and the overall market.
Key Points
- Sun Pharma stock down 0.29% today, benchmark NIFTY down 0.17%.
- Stock dropped 9.23% in the last year, while NIFTY rose 9.53%.
- Nifty Pharma index decreased by 2.07% over the last month.
- Stock volume today is lower than the last month’s average.
- PE ratio stands at 88.17, reflecting market valuation expectations.
- December futures contract up 0.02%, indicating short-term sentiment.
Recent Performance
Over the past few days, the stock has been falling for the fifth time in a row. This indicates a possible trend of selling pressure. The benchmark NIFTY index is also down slightly today, at 25897.6, and the Sensex is down 0.16%, showing a general downturn in the market.
Comparison with Other Investments
While Sun Pharma’s stock has fallen 9.23% over the last year, the NIFTY (a general measure of the stock market) has gone up 9.53%. Also, the Nifty Pharma index, which includes Sun Pharma, has decreased by 4.26% over the same period. This comparison helps us see where Sun Pharma stands relative to the broader market and its industry.
Short-Term Changes
In the last month, Sun Pharma’s stock price has decreased by around 5.27%, and the Nifty Pharma index has also decreased by 2.07%, currently at 22578.3. The trading volume today was 9.85 lakh shares, which is lower than the usual 20.24 lakh shares traded in the last month. The December futures contract for the stock is up 0.02% today.
Financial Valuation
Sun Pharma’s Price-to-Earnings (PE) ratio is 88.17, based on its financial results ending in September. This number tells us how much investors are willing to pay for each rupee of the company’s earnings. A higher PE ratio generally suggests that investors expect the company to grow quickly.
The market reflects investor sentiment; understanding shifts is crucial for informed decisions.
